nektar therapeutics (NKTR:NASDAQ GS)
Stephen K. Doberstein Ph.D.
Chief Scientific Officer and Senior Vice President, Nektar Therapeutics
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 5 different industries.|
As of Fiscal Year 2013
Dr. Stephen K. Doberstein, Ph.D, Steve has been Chief Scientific Officer and Senior Vice President of Nektar Therapeutics since January 6, 2010. Dr. Doberstein served as Vice President of Research of XOMA Ltd. since October 28, 2008. He has 17 years of experience in biotechnology research and development. Most recently, he served as Vice President of Research at Five Prime Therapeutics, Inc., since July 2004. Prior to his position at Five Prime, he served as Vice President ...
455 Mission Bay Boulevard SouthPhone: 415-482-5300
San Francisco, California 94158
Board Members Memberships*There is no Board Members Memberships data available.
University of Delaware
Johns Hopkins School of Medicine
|Michael W. Aguiar||Chief Executive Officer, President and Director|
|Peter M. Hecht Ph.D.||Co-Founder, Chief Executive Officer and Director|
Ironwood Pharmaceuticals, Inc.
|James A. Schoeneck||Chief Executive Officer, President and Director|
|Richard Martin Steeves Ph.D.||Group Chief Executive Officer, Member of Senior Executive Board and Executive Director|
Synergy Health plc
|Daniel J. Abdun-Nabi||Chief Executive Officer, President, Director and Member of Strategic Operations Committee|
Emergent BioSolutions, Inc.
|$1.0M||Compensation as of Fiscal Year 2013.|